Komori
Presentation materials for financial results6645OMRON CorporationElectrical Equipment and Precision Instruments

Presentation Materials for the Fiscal Year Ending March 2026 Results

In FY2025, company-wide revenue and operating profit increased, driven by the recovery of the control equipment business and growing demand related to AI. In FY2026, the company plans to increase revenue and operating profit across the company and all segments, and forecasts annual dividends of ¥110, up ¥6 year on year.

Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
65
¥100 million (year-on-year increase in operating profit)
Wording
Conditional
How definitive the wording is.

Contents of this document

Presentation materials for financial resultsFY2025 actual results, FY2026 plan7 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Operating profit
Value
FY2025 actual599
Fiscal 2026 Plan620
Full-year earnings forecast
Operating profit
620 Hundreds of millions of yen
Annual Dividend
¥110
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Foreign Exchange Effects+¥3.1 billion
  • Increase in gross profit from higher sales+¥21.4 billion
  • Decline in Gross Profit Margin-¥5.4 billion
  • Increase in fixed costs-¥12.6 billion
  • Increase in SG&A expenses-¥6.9 billion
  • Increase in R&D expenses-¥5.7 billion
  • Other
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
  • ¥155
    AssumptionsU.S. dollar exchange rate assumption
  • ¥180
    AssumptionsEuro exchange rate assumption
  • ¥22
    AssumptionsRenminbi exchange rate assumption
New initiatives
  • Release 22 new products in the control equipment business in FY2026
  • Provide industry-specific solutions for semiconductor manufacturing equipment and secondary battery manufacturers
  • Prioritize M&A to strengthen the customer base
  • Corporate demerger and share transfer involving the electronic components business
  • Validate the accuracy of the disease risk prediction algorithm toward commercializing the business
Key KPIsA metric the company considers important as a management benchmark.
  • Control equipment business 4Q order level1.41 vs. FY22 4Q
  • AXI sales+140% year on year
    Year on year against the same period last year+140%
  • Semiconductor industry sales+20% year on year
    Year on year against the same period last year+20%
  • Secondary battery industry sales+27% year on year
    Year on year against the same period last year+27%
  • Disease risk prediction algorithm accuracyApproximately 0.9
Medium-term management plan targets
  • TargetControl equipment business operating margin
    Target value16.0%
    Target fiscal year2030
  • TargetExpansion rate of Customer Base Map coverage
    Target value160% vs. FY24
    Target fiscal yearFY30
  • TargetBlood pressure monitor unit sales
    Target value31.72 million units
    Target fiscal yearFY30
Annual Dividend
¥110
Interim and Year-End BreakdownUndecided
Acquisition of treasury shares
Explains the criteria for executing share repurchases. The amount, number of shares and period of the repurchase authorization are not disclosed
Contents of this document
ItemDetails
Document typePresentation materials for financial results
Fiscal Period CoveredFY2025 actual results, FY2026 plan
Operating profitvalue FY2025 actual 599 / Fiscal 2026 Plan 620 / yoy_pct Not disclosed
Full-year earnings forecastOperating profit 620 Hundreds of millions of yen / Annual Dividend ¥110
Breakdown of Factors Affecting the ChangeFactors Foreign Exchange Effects / Amount +¥3.1 billion, Factors Increase in gross profit from higher sales / Amount +¥21.4 billion, Factors Decline in Gross Profit Margin / Amount -¥5.4 billion, Factors Increase in fixed costs / Amount -¥12.6 billion, Factors Increase in SG&A expenses / Amount -¥6.9 billion, Factors Increase in R&D expenses / Amount -¥5.7 billion, Factors Other / Amount Not disclosed
Key KPIsIndicator name Control equipment business 4Q order level / Value 1.41 vs. FY22 4Q / Year on year against the same period last year Not disclosed, Indicator name AXI sales / Value +140% year on year / Year on year against the same period last year +140%, Indicator name Semiconductor industry sales / Value +20% year on year / Year on year against the same period last year +20%, Indicator name Secondary battery industry sales / Value +27% year on year / Year on year against the same period last year +27%, Indicator name Disease risk prediction algorithm accuracy / Value Approximately 0.9 / Year on year against the same period last year Not disclosed
Assumptions Underlying the Business OutlookAssumptions U.S. dollar exchange rate assumption / Value ¥155, Assumptions Euro exchange rate assumption / Value ¥180, Assumptions Renminbi exchange rate assumption / Value ¥22
Medium-term management plan targetsTarget Control equipment business operating margin / Target value 16.0% / Target fiscal year 2030, Target Expansion rate of Customer Base Map coverage / Target value 160% vs. FY24 / Target fiscal year FY30, Target Blood pressure monitor unit sales / Target value 31.72 million units / Target fiscal year FY30
Annual Dividend¥110
Acquisition of treasury sharesExplains the criteria for executing share repurchases. The amount, number of shares and period of the repurchase authorization are not disclosed
New initiativesRelease 22 new products in the control equipment business in FY2026, Provide industry-specific solutions for semiconductor manufacturing equipment and secondary battery manufacturers, Prioritize M&A to strengthen the customer base, Corporate demerger and share transfer involving the electronic components business, Validate the accuracy of the disease risk prediction algorithm toward commercializing the business
Items this document does not state (20)
Net SalesOrdinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planSegment resultsUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookFinancial targetsPayout ratioCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In FY2025, the recovery of the customer base in the control equipment business and growing demand related to AI drove performance. Operating profit benefited from an increase in gross profit due to higher sales, which absorbed the decline in the gross margin and increases in fixed costs, SG&A expenses and R&D expenses. For FY2026, the plan incorporates expectations for steady demand, sales growth and an improvement in the gross margin, while also factoring in uncertainty related to the situation in the Middle East and a certain degree of cost impact.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Presentation Materials for the Fiscal Year Ending March 2026 Results | OMRON Corporation (6645) timely disclosure | Komori